1,405
Views
0
CrossRef citations to date
0
Altmetric
Review Article

Swedish obstetric thromboprophylaxis guideline: background and update

, &
Article: 2241527 | Received 29 Apr 2023, Accepted 23 Jul 2023, Published online: 08 Aug 2023

References

  • Bates, S.M., et al., 2018. American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy. Blood Advances, 2 (22), 3317–3359.
  • Bernstein, C.N., et al., 2001. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thrombosis and Haemostasis, 85 (3), 430–434.
  • Blomback, M., et al., 1998. A pharmacokinetic study of dalteparin (Fragmin) during late pregnancy. Blood Coagulation & Fibrinolysis: An International Journal in Haemostasis and Thrombosis, 9 (4), 343–350.
  • Brooks, C., et al., 2002. Warfarin dosage in postpartum women: a case–control study. BJOG: An International Journal of Obstetrics and Gynaecology, 109 (2), 187–190.
  • Chauleur, C., et al., 2008. Feasibility of an easy-to-use risk score in the prevention of venous thromboembolism and placental vascular complications in pregnant women: a prospective cohort of 2736 women. Thrombosis Research, 122 (4), 478–484.
  • Christiansen, S.C., et al., 2010. Sex difference in risk of recurrent venous thrombosis and the risk profile for a second event. Journal of Thrombosis and Haemostasis, 8 (10), 2159–2168.
  • Dargaud, Y., et al., 2009. A risk score for the management of pregnant women with increased risk of venous thromboembolism: a multicentre prospective study. British Journal of Haematology, 145 (6), 825–835.
  • Epstein, D., Kvanta, A., and Lindqvist, P.G., 2015. Seasonality and incidence of central retinal vein occlusion in Sweden: a 6-year study. Ophthalmic Epidemiology, 22 (2), 94–97.
  • Grainge, M.J., West, J., and Card, T.R., 2010. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet (London, England), 375 (9715), 657–663.
  • Hem-ARG. 2004. Arbets och referensgruppen för hemostasrubbningar. Hemostasrubbningar inom obstetrik och gynekologi. Stockholm, Sweden.
  • Henriksson, P., et al., 2013. Incidence of pulmonary and venous thromboembolism in pregnancies after in vitro fertilisation: cross sectional study. BMJ (Clinical Research Ed.), 346, e8632.
  • Jacobsen, A.F., Skjeldestad, F.E., and Sandset, P.M., 2008a. Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium – a register-based case-control study. American Journal of Obstetrics & Gynecology, 198, 233.e1–237.
  • Jacobsen, A.F., Skjeldestad, F.E., and Sandset, P.M., 2008b. Ante- and postnatal risk factors of venous thrombosis: a hospital-based case–control study. Journal of Thrombosis and Haemostasis, 6 (6), 905–912.
  • James, A.H., et al., 2006. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. American Journal of Obstetrics and Gynecology, 194 (5), 1311–1315.
  • Knight, M. 2008. Antenatal pulmonary embolism: risk factors, management and outcomes. BJOG: An International Journal of Obstetrics and Gynaecology, 115 (4), 453–461.
  • Larsen, T.B., et al., 2007. Maternal smoking, obesity, and risk of venous thromboembolism during pregnancy and the puerperium: a population-based nested case-control study. Thrombosis Research, 120 (4), 505–509.
  • Lindqvist, P.G., Bremme, K., and Hellgren, M., 2010. Efficasy of obstetric thromboprophylaxis and the long-term risk of recurrences. Acta Obstetricia et Gynaecologia Scandinavica, 90 (6), 648–653.
  • Lindqvist, P., Dahlbäck, B., and Marŝál, K., 1999. Thrombotic risk during pregnancy: a population study. Obstetrics and Gynecology, 94 (4), 595–599.
  • Lindqvist, P.G., Epstein, E., and Landin-Olsson, M., 2022. Sun exposure – hazards and benefits. Anticancer Research, 42 (4), 1671–1677.
  • Lindqvist, P.G., Epstein, E., and Olsson, H., 2009a. The relationship between lifestyle factors and venous thromboembolism among women: a report from the MISS study. British Journal of Haematology, 144 (2), 234–240.
  • Lindqvist, P.G., Epstein, E., and Olsson, H., 2009b. Does an active sun exposure habit lower the risk of venous thrombotic events? A D-lightful hypothesis. Journal of Thrombosis and Haemostasis, 7 (4), 605–610.
  • Lindqvist, P.G. and Hellgren, M., 2011. Obstetric thromboprophylaxis: the Swedish guidelines. Advances in Hematology, 2011, 157483.
  • Lindqvist, P.G., Kublikas, M., and Dahlbäck, B., 2002. Individual risk assessment of thrombosis in pregnancy. Acta Obstetricia et Gynecologica Scandinavica, 81 (5), 412–416.
  • Lindqvist, P.G., Olofsson, P., and Dahlbäck, B., 2002. Use of selective factor V Leiden screening in pregnancy to identify candidates for anticoagulants. Obstetrics and Gynecology, 100 (2), 332–336.
  • Lindqvist, P.G., et al., 2008. Postpartum thromboembolism: severe events might be preventable using a new risk score model. Vascular Health and Risk Management, 4 (5), 1081–1087.
  • Liu, S., et al., 2009. Epidemiology of pregnancy-associated venous thromboembolism: a population-based study in Canada. Journal of Obstetrics and Gynaecology Canada, 31 (7), 611–620.
  • MacGregor, B., et al., 2022. MBRRACE 2021: preventing maternal deaths – we are all part of the solution. The British Journal of General Practice, 72 (717), 148–149.
  • Macklon, N.S. and Greer, I.A., 1996. Venous thromboembolic disease in obstetrics and gynaecology: the Scottish experience. Scottish Medical Journal, 41 (3), 83–86.
  • Marik, P.E. and Plante, L.A., 2008. Venous thromboembolic disease and pregnancy. The New England Journal of Medicine, 359 (19), 2025–2033.
  • Nagaraja, D., et al., 2008. Homocysteine, folate and vitamin B(12) in puerperal cerebral venous thrombosis. Journal of the Neurological Sciences, 272 (1-2), 43–47.
  • Nelson-Piercy, C., MacCallum, P., and Mackillop, L., 2015. Reducing the risk of thrombosis and embolism during pregnancy and the puerperium. RCOG Green-top Guideline No. 37a, Royal College of Obstetricians and Gynaecologists, London, UK.
  • Norris, L.A., et al., 2004. Low molecular weight heparin (tinzaparin) therapy for moderate risk thromboprophylaxis during pregnancy. A pharmacokinetic study. Thrombosis and Haemostasis, 92 (4), 791–796.
  • Prochazka, M., et al., 2003. Factor V Leiden in pregnancies complicated by placental abruption. BJOG: An International Journal of Obstetrics and Gynaecology, 110 (5), 462–466.
  • Rova, K., Passmark, H., and Lindqvist, P.G., 2012. Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles. Fertility and Sterility, 97 (1), 95–100.
  • Salonen Ros, H., et al., 2001. Increased risks of circulatory diseases in late pregnancy and puerperium. Epidemiology, 12 (4), 456–460.
  • Saposnik, G., et al., 2011. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 42 (4), 1158–1192.
  • Sultan, A.A., et al., 2016. Development and validation of risk prediction model for venous thromboembolism in postpartum women: multinational cohort study. BMJ (Clinical Research Ed.), 355, i6253.
  • Thrombosis Canada. 2023. Pregnancy thromboprophylaxis. Available from: https://thrombosiscanada.ca/ clinical_guides/pdfs/THROMBOPROPHYLAXISINPREGNANCY_39.pdf [Accessed 15 Jun 2023].
  • Thurn, L., Wikman, A., and Lindqvist, P.G., 2018. Postpartum blood transfusion and hemorrhage as independent risk factors for venous thromboembolism. Thrombosis Research, 165, 54–60.
  • Tuffnell, D., Knight, M., and Mackillop, L., 2018. Lessons for prevention and treatment of thrombosis and thromboembolism. In: MBRRACE-UK. Saving Lives, Improving Mothers’ Care 2018. Chapter 4, Oxford: National Perinatal Epidemiology Unit, University of Oxford, UK, 34–46.